SCHEMBL249927

SCHEMBL249927

CC(=O)C(C)COC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16359309 0.81
SCHEMBL6722444 0.79
SCHEMBL9508848 0.79 TSHR (0.30)
SCHEMBL5215551 0.77 SMN1; SMN2 (0.37)
Acetic Acid SCHEMBL9466139 0.76 TSHR (0.40)
SCHEMBL11914186 0.76 CHRNB2 (0.32)
SCHEMBL11914182 0.73
SCHEMBL2161007 0.73 TSHR (0.47)
SCHEMBL15826906 0.72
SCHEMBL1254462 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150094284-A1 S-TRIAZOLYL ALPHA-MERCAPTO ACETANILIDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE ARDEA BIOSCIENCES, INC. 2015-04-02 US claimed
EP-1789039-A4 S-TRIAZOLYL ALPHA -MERCAPTOACETANILDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE ARDEA BIOSCIENCES INC (US) 2009-08-05 EP claimed
JP-2008510828-A 2008-04-10 JP claimed
EP-1789039-A2 S-TRIAZOLYL ALPHA -MERCAPTOACETANILDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE Ardea Biosciences, Inc. (US) 2007-05-30 EP claimed
WO-2006026356-A2 S-TRIAZOLYL α-MERCAPTOACETANILDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE ARDEA BIOSCIENCES, INC. (US) 2006-03-09 WO claimed
EP-2609917-A1 Triazolyl alpha -mercaptoacetanilides as inhibitors of HIV reverse transcriptase Ardea Biosciences, Inc. (US) 2013-07-03 EP disclosed
EP-2402011-B1 S-triazolyl alpha-mercaptoacetanilides as inhibitors of HIV reverse transcriptase ARDEA BIOSCIENCES INC (US) 2012-11-14 EP disclosed
EP-2433633-A1 Triazolyl alpha -mercaptoacetanildes as inhibitors of HIV reverse transcriptase Ardea Biosciences, Inc. (US) 2012-03-28 EP disclosed
EP-2402011-A1 Intermediates in the synthesis of S-triazolyl alpha-mercaptoacetanildes as inhibitors of HIV reverse transcriptase Ardea Biosciences, Inc. (US) 2012-01-04 EP disclosed